A report on Plasmodium ovale, Malaria and Primaquine
Plasmodium ovale is a species of parasitic protozoa that causes tertian malaria in humans.
- Plasmodium ovalePrimaquine is a medication used to treat and prevent malaria and to treat Pneumocystis pneumonia.
- PrimaquineSpecifically it is used for malaria due to Plasmodium vivax and Plasmodium ovale along with other medications and for prevention if other options cannot be used.
- PrimaquineMost deaths are caused by P. falciparum, whereas P. vivax, P. ovale, and P. malariae generally cause a milder form of malaria.
- MalariaStandard treatment is concurrent treatment with chloroquine and primaquine.
- Plasmodium ovaleTreatment of P. vivax requires both treatment of blood stages (with chloroquine or artemisinin-based combination therapy) and clearance of liver forms with an 8-aminoquinoline agent such as primaquine or tafenoquine.
- Malaria1 related topic with Alpha
Plasmodium vivax
0 linksProtozoal parasite and a human pathogen.
Protozoal parasite and a human pathogen.
This parasite is the most frequent and widely distributed cause of recurring malaria.
P. vivax and P. ovale that has been sitting in EDTA for more than 30 minutes before the blood film is made will look very similar in appearance to P. malariae,[source needed] which is an important reason to warn the laboratory immediately when the blood sample is drawn so they can process the sample as soon as it arrives.
Where an artemisinin-based combination therapy has been adopted as the first-line treatment for P. falciparum malaria, it may also be used for P. vivax malaria in combination with primaquine for radical cure.